文献速递类风湿关节炎

类风湿关节炎滑膜微环境的时空图谱揭示与治疗应答相关的LYVE1+巨噬细胞网络

Spatial mapping of rheumatoid arthritis synovial niches reveals a LYVE1+ macrophage network associated with response to therapy.
PubMed 文献 · Ann Rheum Dis · 2025-08-22

本研究对健康对照、骨关节炎及早期类风湿关节炎患者滑膜行高维成像质谱流式,纵向比较csDMARD治疗6个月前后的变化,发现位于血管周微环境的LYVE1+CD206+组织驻留巨噬细胞网络在活动性类风湿关节炎中 disrupted、在应答良好者中恢复,体外显示其具调节性抗炎表型。

要点

  • LYVE1+CD206+组织驻留巨噬细胞网络位于血管周微环境,与成纤维细胞和血管细胞共存。
  • 该稳态网络在活动性类风湿关节炎中被破坏,csDMARD应答良好者中恢复。
  • 网络恢复与趋化因子、膜联蛋白及TAM受体等分子通路再建立特定细胞间相互作用相关。

核心结论

  • 本研究提供类风湿关节炎滑膜治疗应答的空间与动态蓝图,LYVE1+巨噬细胞网络是滑膜稳态的关键组分,其恢复是临床缓解的标志。

研究设计与样本

  • 对健康对照、骨关节炎及早期类风湿关节炎患者滑膜组织行高维成像质谱流式,早期类风湿关节炎患者在csDMARD治疗6个月前后的纵向样本。
  • 用全组织RNA测序和免疫荧光在更大队列中验证,并整合公共单细胞RNA测序数据集的配体-受体分析及体外功能共培养实验。

主要发现

  • 深度空间分析定位到位于血管周微环境、与成纤维细胞和血管细胞共存的LYVE1+CD206+组织驻留巨噬细胞网络。
  • 该稳态网络在活动性类风湿关节炎中被破坏,而在csDMARD应答良好患者中恢复。
  • 网络恢复与特定细胞间相互作用的再建立相关,受趋化因子、膜联蛋白和TAM(TYRO3、AXL、MERTK)受体等分子通路调控。
  • 体外实验中LYVE1+巨噬细胞表现调节性抗炎表型,与促炎髓系细胞形成对比。

关键数值与推荐

  • 原文未报告具体阈值、比例或推荐等级。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Despite advances in rheumatoid arthritis (RA) treatment, a significant proportion of patients fail to achieve adequate remission. The dynamic cellular and architectural changes within the synovium that underpin therapeutic success remain poorly understood. This study aimed to unravel the synovial landscape during effective RA treatment, identifying key cellular networks and molecular pathways associated with remission. METHODS: We performed high-dimensional imaging mass cytometry on synovial tissues from healthy controls, patients with osteoarthritis, and patients with early RA longitudinally before and after 6 months of conventional synthetic disease-modifying antirheumatic drugs (csDMARD) therapy. Findings were validated using whole-tissue RNA-sequencing and immunofluorescence in larger patient cohorts, and integrated with ligand-receptor analyses from public single-cell RNA-seq datasets and in vitro functional coculture assays. RESULTS: Our deep spatial profiling pinpointed a critical LYVE1+CD206+tissue-resident macrophage network, localised within perivascular niches alongside fibroblasts and vascular cells. This homeostatic network was disrupted in active RA but restored in patients responding well to csDMARDs. This restoration correlated with the re-establishment of specific cell-cell interactions and was governed by distinct molecular pathways, including chemokines, annexins, and TAM (TYRO3, AXL, MERTK) receptors. Functionally, LYVE1+ macrophages demonstrated a regulatory, anti-inflammatory phenotype in vitro, contrasting with proinflammatory myeloid cells. CONCLUSIONS: This study provides an unprecedented spatial and dynamic blueprint of the RA synovium's response to therapy. We identify the LYVE1+ macrophage network as a pivotal component of synovial homeostasis and its restoration as a hallmark of clinical remission. These findings unveil novel cellular and molecular targets, paving the way for more active therapeutic strategies.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. De Lima J, Boutet MA, Bortolotti O, et al. Spatial mapping of rheumatoid arthritis synovial niches reveals a LYVE1+ macrophage network associated with response to therapy. Ann Rheum Dis. 2025. PMID: 40849271. doi:10.1016/j.ard.2025.07.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。